Topical drug formulations for prolonged corneal anesthesia

Cornea

Volumn 32, Issue 7, 2013, Pages 1040-1045

  Wang, Liqiang ^a,b,c   Shankarappa, Sahadev A ^c,d   Tong, Rong ^c,d   Ciolino, Joseph B ^a,d   Tsui, Jonathan H ^c,d   Chiang, Homer H ^c,d   Kohane, Daniel S ^c,d  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Corneal anesthesia; Corneal toxicity; Proparacaine; Tetrodotoxin

Indexed keywords

OCTYL TRIMETHYL AMMONIUM BROMIDE; PENETRATION ENHANCING AGENT; PROXYMETACAINE; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CLINICAL PRACTICE; COLORIMETRY; CONTROLLED STUDY; CORNEA ANESTHESIA; CORNEA CELL; CORNEA EPITHELIUM; DEBRIDEMENT; DRUG FORMULATION; EPITHELIZATION; EYE PHOTOGRAPHY; EYELID REFLEX; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TACTILE STIMULATION;

ANESTHESIA, LOCAL; ANESTHETICS, COMBINED; ANESTHETICS, LOCAL; ANIMALS; CELL LINE; CHEMISTRY, PHARMACEUTICAL; CORNEA; CORNEAL KERATOCYTES; EPITHELIUM, CORNEAL; HUMANS; MALE; PROPOXYCAINE; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHANNEL BLOCKERS; TETRODOTOXIN; TIME FACTORS; WOUND HEALING;

EID: 84879070607     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31828cbfe6     Document Type: Article

References (27)

1. Ragsdale DS, McPhee JC, Scheuer T, et al. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science. 1994;265:1724-1728.
2. Bartfield JM, Holmes TJ, Raccio-Robak N. A comparison of proparacaine and tetracaine eye anesthetics. Acad Emerg Med. 1994;1: 364-367.
3. Liu JC, Steinemann TL, McDonald MB, et al. Topical bupivacaine and proparacaine: a comparison of toxicity, onset of action, and duration of action. Cornea. 1993;12:228-232.
4. Gupta N, Naroo SA. Factors influencing patient choice of refractive surgery or contact lenses and choice of centre. Cont Lens Anterior Eye. 2006; 29:17-23.
5. Zhang M-M, Gruszczynski P, Walewska A, et al. Cooccupancy of the outer vestibule of voltage-gated sodium channels by micro-conotoxin KIIIA and saxitoxin or tetrodotoxin. J Neurophysiol. 2010;104:88-97.
6. Kohane DS, Lu NT, Gökgöl-Kline AC, et al. The local anesthetic properties and toxicity of saxitonin homologues for rat sciatic nerve block in vivo. Reg Anesth Pain Med. 2000;25:52-59.
7. Padera RF, Tse JY, Bellas E, et al. Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity. Muscle Nerve. 2006;34:747-753.
8. Barnet CS, Tse JY, Kohane DS. Site 1 sodium channel blockers prolong the duration of sciatic nerve blockade from tricyclic antidepressants. Pain. 2004;110:432-438.
9. Kohane DS, Yieh J, Lu NT, et al. A re-examination of tetrodotoxin for prolonged duration local anesthesia. Anesthesiology. 1998;89:119-131.
10. Simons EJ, Bellas E, Lawlor MW, et al. Effect of chemical permeation enhancers on nerve blockade. Mol Pharm. 2009;6:265-273.
11. Schwartz DM, Fields HL, Duncan KG, et al. Experimental study of tetrodotoxin, a long-acting topical anesthetic. Am J Ophthalmol. 1998;125:481-487.
12. Schwartz DM, Duncan KG, Duncan JL. Experimental use of tetrodotoxin for corneal pain after excimer laser keratectomy. Cornea. 1998;17:196-199.
13. Lawrenson JG, Ruskell GL. Investigation of limbal touch sensitivity using a Cochet-Bonnet aesthesiometer. Br J Ophthalmol. 1993;77:339-343.
14. Kim TI, Chung JL, Hong JP, et al. Bevacizumab application delays epithelial healing in rabbit cornea. Invest Ophthalmol Vis Sci. 2009;50:4653-4659.
15. Sagie I, Kohane DS. Prolonged sensory-selective nerve blockade. Proc Natl Acad Sci U S A. 2010;107:3740-3745.
16. Lu L, Reinach PS, Kao WW. Corneal epithelial wound healing. Exp Biol Med (Maywood). 2001;226:653-664.
17. Adams HJ, Blair MR, Takman BH. The local anesthetic activity of tetrodotoxin alone and in combination with vasoconstrictors and local anesthetics. Anesth Analg. 1976;55:568-573.
18. Staiman AL, Seeman P. Different sites of membrane action for tetrodotoxin and lipid-soluble anesthetics. Can J Physiol Pharmacol. 1975;53:513-524.
19. Kohane DS, Smith SE, Louis DN, et al. Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain. 2003;104:415-421.
20. Cahalan MD, Almers W. Interactions between quaternary lidocaine, the sodium channel gates, and tetrodotoxin. Biophys J. 1979;27:39-55.
21. Karande P, Jain A, Ergun K, et al. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci U S A. 2005;102:4688-4693.
22. Marfurt C, Cox J, Deek S. Anatomy of the human corneal innervation. Exp Eye Res. 2010;90:478-492.
23. Kao CY. Pharmacology of tetrodotoxin and saxitoxin. Fed Proc. 1972; 31:1117-1123.
24. Oksala O, Stjernschantz J, Dickhoff von K. Characterization of the mechanism of acute ocular irritation to YAG laser capsulotomy in rabbits: effects of substance P antagonists, Met-enkephalin, tetracaine and tetrodotoxin. Ophthalmic Res. 1989;21:360-368.
25. Schwartz DM, Duncan KG, Fields HL, et al. Tetrodotoxin: anesthetic activity in the de-epithelialized cornea. Graefes Arch Clin Exp Ophthalmol. 1998;236:790-794.
26. Marfurt CF, Kingsley RE, Echtenkamp SE. Sensory and sympathetic innervation of the mammalian cornea. A retrograde tracing study. Invest Ophthalmol Vis Sci. 1989;30:461-472.
27. Araki K, Ohashi Y, Kinoshita S, et al. Epithelial wound healing in the denervated cornea. Curr Eye Res. 1994;13:203-211.